⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL305909 | 1.00 | — | — | |
| SCHEMBL6196827 | 1.00 | — | — | |
| SCHEMBL901476 | 1.00 | — | — | |
| SCHEMBL900297 | 1.00 | — | — | |
| SCHEMBL661917 | 1.00 | — | — | |
| SCHEMBL16635328 | 1.00 | — | — | |
| SCHEMBL187963 | 1.00 | — | — | |
| SCHEMBL901466 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL6201099 | 0.98 | CYP2D6 (0.56) | — | |
| Hydrochloric Acid SCHEMBL21598085 | 0.98 | CYP2D6 (0.56) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1617 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4745151-A1 | FIBROBLAST ACTIVATION PROTEIN LIGAND AND USE THEREOF | Jiangsu Hengrui Pharmaceuticals Co., Ltd. (CN) | 2026-05-20 | — | — | EP | claimed |
| US-12600699-B2 | Thiosemicarbazates and uses thereof | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH (US) | 2026-04-14 | — | — | US | claimed |
| US-20250325672-A1 | ANTI-INFECTIVE BICYCLIC PEPTIDE LIGANDS | BICYCLE TX LTD (GB) | 2025-10-23 | — | — | US | claimed |
| US-12428447-B2 | Peptide-based non-proteinaceous cargo delivery | FELDAN BIO INC. (CA) | 2025-09-30 | — | — | US | claimed |
| WO-2025149851-A2 | METHODS FOR TREATING INFLAMMATORY DISEASES | YUYU PHARMA, INC. (KR) | 2025-07-17 | — | — | WO | claimed |
| US-12351573-B2 | Compounds for use in synthesis of peptidomimetics | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH (US) | 2025-07-08 | — | — | US | claimed |
| WO-2025085511-A1 | SYSTEMS AND METHODS FOR POLYMER-MEDIATED ACTIVATION OF ENGINEERED CELLS | UNIVERSITY OF WASHINGTON (US) | 2025-04-24 | — | — | WO | claimed |
| WO-2025011611-A1 | FIBROBLAST ACTIVATION PROTEIN LIGAND AND USE THEREOF | 江苏恒瑞医药股份有限公司 | 2025-01-16 | — | — | WO | claimed |
| CN-118984715-A | Compositions for the treatment of macular degeneration comprising novel peptides | 韩国视角生物株式会社 | 2024-11-19 | — | — | CN | claimed |
| EP-4450079-A1 | COMPOSITION FOR TREATING MACULAR DEGENERATION COMPRISING NOVEL PEPTIDE | EyebioKorea, Inc. (KR) | 2024-10-23 | — | — | EP | claimed |
| EP-1017358-A1 | REDUCTION OF HAIR GROWTH | THE GILLETTE COMPANY (US) | 2000-07-12 | — | — | EP | claimed |
| WO-1999060099-A1 | AMINO ACID MODIFIED POLYPEPTIDES | UNITED STATES SURGICAL CORPORATION (US) | 1999-11-25 | — | — | WO | claimed |
| US-5939458-A | APPLYING AN INHIBITOR OF AMINOACYL-TRNA SYNTHETASE TO THE SKIN | GILLETTE COMPANY, THE | 1999-08-17 | — | — | US | claimed |
| WO-1999015136-A1 | REDUCTION OF HAIR GROWTH | THE GILLETTE COMPANY (US) | 1999-04-01 | — | — | WO | claimed |
| US-5720950-A | ALKOXYLATED PROLINE ANALOG | UNIVERSITY OF MEDICINE & DENTISTRY OF NEW JERSEY (US) | 1998-02-24 | — | — | US | claimed |
| US-5660822-A | A PROLINE ANALOG LINKED TO A POLYOXYALKYLENE ETHER THROUGH A SPACER COMPOUND SUCH AS LYSINE; CONTROLLING THE PROLIFERATION OF COLLAGEN; TIME-RELEASE AGENTS; NONTOXIC | UNIVERSITY OF MEDICINE & DENTISTRY OF N.J. (US) | 1997-08-26 | — | — | US | claimed |
| US-5658885-A | OLIGOPEPTIDES; ANTICOAGULANTS; ENZYME INHIBITORS; THROMBIN | THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) | 1997-08-19 | — | — | US | claimed |
| US-5372807-A | Proline analogs administered to inhibit collagen accumulation | UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY (US) | 1994-12-13 | — | — | US | claimed |
| EP-0078191-B1 | COLLAGEN INHIBITING COMPOSITIONS AND PROCESSES FOR MANUFACTURING AND USING THE SAME | UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY (US) | 1986-09-03 | — | — | EP | claimed |
| US-4482725-A | ANGIOTENSIN CONVERTING ENZYME INHIBITOR | E. R. SQUIBB & SONS, INC. (US) | 1984-11-13 | — | — | US | claimed |